Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1057 | 1098 | 1155 | 1293 | 1833 | 3098 |
Fund Return | 5.68% | 9.77% | 15.52% | 8.93% | 12.88% | 11.97% |
Place in category | 1913 | 2214 | 1905 | 542 | 330 | 285 |
% in Category | 64 | 72 | 64 | 26 | 23 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GS India Equity Portfolio Other Cug | 3.49B | 4.68 | 14.24 | 14.73 | ||
GS India Equity Portfolio R GBP Inc | 3.49B | 4.94 | 15.28 | 15.77 | ||
GS EM Equity Portfolio Other Curren | 2.89B | 4.84 | -7.19 | 6.22 | ||
GS EM Equity Portfolio R GBP Inc | 2.89B | 5.10 | -6.35 | 7.15 | ||
GS EM Equity Portfolio IO GBP Acc | 2.89B | 5.34 | -5.51 | 8.21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 15.18B | 9.59 | 8.81 | 15.94 | ||
Fundsmith Equity I Inc | 4.56B | 9.59 | 8.81 | 15.93 | ||
Fundsmith Equity R Acc | 593.71M | 9.43 | 8.16 | 15.23 | ||
Fundsmith Equity R Inc | 18.15M | 9.43 | 8.16 | 15.22 | ||
Fundsmith Equity T Acc | 4.13B | 9.56 | 8.70 | 15.82 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 7.16 | 406.32 | +1.82% | |
Amazon.com | US0231351067 | 4.43 | 179.62 | +3.43% | |
Procter&Gamble | US7427181091 | 3.83 | 161.24 | -0.81% | |
AstraZeneca | GB0009895292 | 3.68 | 11,988.0 | -0.32% | |
DSM Firmenich | CH1216478797 | 3.60 | 105.30 | +2.53% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review